Pediatric Myasthenia Gravis: Future Directions and Treatment Gaps

“I really want us to get a better understanding of pediatric myasthenia gravis,” he says, “and how we can follow these patients and best take care of them safely.” Strober specializes in neuromuscular disorders at the University of california, San Francisco, and Benioff Children’s Hospital, where he is director both of clinical services for child neurology and of the muscular dystrophy clinic.

Rewatch part 1 for insight on nipocalimab use in these younger patients and part 2.